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P U B L I S H E D B Y E L S E V I E R I N C .LETTERS TO THE EDITORSuperﬁcial Calcium Fracture After PCI as
Assessed by OCTHeavily calciﬁed lesions in coronary arteries have
been known to cause stent underexpansion, which
increases the risk of in-stent restenosis (1,2). Plaque
modiﬁcation before stent implantation is considered
to be the key for treatment of calciﬁed lesions
(3). We hypothesized that calcium fracture by percu-
taneous coronary intervention (PCI) might be associ-
ated with adequate stent expansion and favorable
late outcome.
From the coronary catheterization registry of
Wakayama Medical University between February 1,
2010 and August 31, 2013, we retrospectively selected
61 patients with chronic stable angina who had a
heavily calciﬁed culprit lesion on coronary angio-
graphy. The heavily calciﬁed lesion on coronary angi-
ography was identiﬁed by radiopacities noted without
cardiac motion before contrast injection, generallyntative OCT Images of Calcium Fracture and Analyzed Data
e tomography (OCT) (LUNAWAVE, Terumo, Tokyo, Japan) before
ry intervention (PCI) (a) showed entire circumferential calcium. OCT
lasty (b) and after PCI (c) demonstrated calcium fracture (6 o’clock).
ium fracture was 710 mm (arrows). Arrowhead ¼ stent strut;
W ¼ guidewire. (B) The distribution of calcium fracture thickness
edian ¼ 450 mm; lower quartile ¼ 300 mm; upper quartile ¼ 660 mm;
maximum ¼ 770 mm.compromising both sides of the arterial lumen (4).
Everolimus-eluting stent was used for PCI. PCI pro-
cedures including stent size, pre- and post-dilation,
and inﬂation pressure were determined by each
physician. Optical coherence tomography (OCT) was
performed before and immediately after PCI. Maximal
calcium thickness, maximal calcium arc, and maximal
calcium length were measured on each candidate
frame selected by visual screening in the OCT images
before PCI. Calcium fracture and stent expansion were
assessed in the OCT images immediately after PCI.
Calcium fracture was characterized by a gap of calcium
and direct exposure of calcium to the lumen at the gap
(Figure 1A). The calcium fracture thickness was
measured at the edge of the fracture. The minimal
stent area wasmeasured on a candidate frame selected
by visual screening. Stent expansion index was calcu-
lated as the minimal stent area divided by the average
of the proximal and distal reference lumen area.
Scheduled follow-up angiography was conducted 10
months after PCI.
Calcium fracture was seen in 29 patients (48%) by
OCT. Baseline clinical characteristics, angiographic
ﬁndings before PCI, stent proﬁles, maximal balloon
diameter, and maximal inﬂation pressure were not
different between the groups with and without cal-
cium fracture. The frequency of cutting balloon
angioplasty or rotational atherectomy before stent
implantation was signiﬁcantly higher in the group
with calcium fracture compared with the group
without calcium fracture (24% vs. 3%; p ¼ 0.022).
Percent diameter stenosis immediately after PCI was
signiﬁcantly smaller in the group with calcium frac-
ture compared with the group without calcium frac-
ture (5  4% vs. 8  6%; p ¼ 0.027).
OCT-measured maximal calcium thickness, maxi-
mal calcium arc, and maximal calcium length were not
different between the groupswith andwithout calcium
fracture. The median calcium fracture thickness was
450 mm (interquartile range: 300 to 660 mm). The
maximal calcium fracture thickness was 770 mm
(Figure 1B). The minimal stent area was signiﬁcantly
greater in the group with calcium fracture compared
with the group without calcium fracture (5.02  1.43
mm2 vs. 4.33  1.22 mm2; p ¼ 0.047). Stent expansion
index was signiﬁcantly greater in the group with cal-
cium fracture compared with the group without cal-
cium fracture (0.88  0.17 vs. 0.78  0.18; p ¼ 0.030).
There was no difference in the frequency of
procedure-related or in-hospital complications in
the groups with and without calcium fracture. The
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1229follow-up angiography at 10 months after PCI was
performed in all patients, and percent diameter
stenosis was signiﬁcantly smaller in the group
with calcium fracture compared with the group
without calcium fracture (19  27% vs. 38  38%;
p ¼ 0.030). The frequency of binary restenosis
(14% vs. 41%; p ¼ 0.024) and ischemic-driven
target lesion revascularization (7% vs. 28%; p ¼
0.046) were signiﬁcantly lower in the group with
calcium fracture compared with the group without
calcium fracture.
OCT offers a unique opportunity to observe plaque
modiﬁcation after PCI in the severe calciﬁed lesion.
Coronary calcium fracture by PCI was associated with
adequate stent expansion and favorable late out-
comes. Our ﬁndings support and underline the need
for optimal lesion preparation in the treatment of
heavily calciﬁed lesions.Takashi Kubo, MD, PhD*
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Sympathetic Nerve PET Tracer LMI1195
in the Isolated Perfused Rabbit HeartA radionuclide tracer approach is a unique assay
to monitor the cardiac sympathetic nervous sys-
tem in patients, and the most widely available
tracer is the radiolabeled norepinephrine analogue
[123I]-metaiodobenzylguanidine ([123I]-MIBG). A novel
18F-labeled positron emission tomography (PET)
tracer, [18F]-LMI1195 (N-[3-bromo-4-(3-[18F]ﬂuoro-
propoxy)-benzyl]-guanidine), has been developed to
overcome the limitations of conventional tracers (1).
[18F]-LMI1195 shares similarities with [123I]-MIBG
based on its benzylguanidine structure, but higher
sensitivity and speciﬁcity and more accurate quanti-
ﬁcation are expected via the general advantages of
PET over single-photon emission computed tomogra-
phy technology. The high speciﬁcity of [18F]-LMI1195
for the norepinephrine transporter was conﬁr-
med with a cell-binding assay and in vivo imaging
(1,2). Most recently, a human volunteer study
demonstrated promising results with uniform tracer
uptake in the ventricular wall and acceptable radiation
doses (3).
We aimed to evaluate further tracer kinetics at the
nerve terminal. First-pass tracer extraction fraction
(EF) and washout were measured in isolated rabbit
hearts (New Zealand White) to avoid systemic recir-
culation and metabolism of the tracer.
The EF was determined at different ﬂow values
(n ¼ 19). Additionally, the inﬂuence of desipramine
hydrochloride (40 nM) added into the buffer (n ¼ 5)
and reserpine–pre-treated hearts (n ¼ 5) were tested.
Reserpine pre-treatment was performed with intra-
venous injection of reserpine (2 mg/kg) 3 h before the
study.
A second protocol was designed to measure tracer
washout. Hearts were perfused with [18F]-LMI1195
added to the buffer for 10 min (incubation phase)
followed by 25 min of perfusion without tracer
(washout phase). The tracer washout was examined
by control Krebs-Henseleit bicarbonate buffer (n ¼ 9),
and desipramine was added (desipramine-chase;
n ¼ 5), with washout with electrical ﬁeld stimulation
(5 Hz, 5 V, 1 min  5 times at the washout phase;
n ¼ 7).
